Clinical Trial Update: Effects Of Exenatide On Liver Biochemistry, Liver Histology And Lipid Metabolism In Patients With Fatty Liver Disease [Phase 2]

View source ↗

Summary

Phase 2 study evaluating exenatide's effects on liver biochemistry, liver histology, and lipid metabolism in fatty liver disease; the trial was terminated with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• EXENATIDE (EXENATIDE)

Snippet

Sponsor: University of California, Davis | Conditions: Diabetes Complications, Fatty Liver | Phase 2 | Status: TERMINATED | Results posted: 2014-12-22